glp 1 afib For patients with obesity and atrial fibrillation, GLP-1 receptor agonist drugs may be the weight loss approach that better addresses their arrhythmia, observational data suggested. https://www.medpagetoday.com/cardiology/arrhythmias/120327 GLP-1 Weight Loss & AFib

Copper peptides are among the earliest investigated candidates in hair growth research

The peptide space is filled with legitimate, exciting science

(PubMed) de Rooij BM, Boogaard PJ, Rijksen DA, Commandeur JN, Vermeulen NP

Multipotency of adult hippocampal NSCs in vivo is restricted by drosha/NFIB

Similar content being viewed by others Introduction Many conventional cancer therapies often lead to undesired side effects because they target proteins and cellular processes necessary for normal cell survival and proliferation, including various progenitor cell types

That study found: Biological aging slowed in 42% of participants, based on the DunedinPACE epigenetic clock